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When mouse L-cells are infected with vesicular stomatitis virus, there is a
decrease in the rate of protein synthesis ranging from 20 to 85% of that in mock-
infected cells. Vesicular stomatitis virus, irradiated with increasing doses of UV
light, eventually loses this capacity to inhibit protein synthesis. The UV inactiva-
tion curve was biphasic, suggesting that transcription of two regions of the viral
genome is necessary for the virus to become inactivated in this capacity. The first
transcription product corresponded to about 373 nucleotides, and the second
corresponded to about 42 nucleotides. Inhibition of transcription of the larger
product by irradiating the virus with low doses ofUV light left a residual inhibition
of protein synthesis consisting of approximately 60 to 65% of the total inhibition.
This residual inhibition could be obviated by irradiating the virus with a UV dose
of greater than 20,000 ergs/mm2 and was thus considered to represent the effect of
the smaller transcription product. In the Rl mutant of C. P. Stanners et al. (Cell
11:273-281, 1977), inhibition of transcription of the larger product sufficed to
restore protein synthesis to the mock-infected level, suggesting that the smaller
transcription product is nonfunctional with respect to protein synthesis inhibition.
It thus appears that the inhibition of protein synthesis by wild-type vesicular
stomatitis virus involved at least two separate viral transcription products, and the
inhibition by the Rl mutant involved only one. Extracts from cells infected with
virus irradiated with low doses of UV light showed a protein synthesis capacity
quite similar to that of their in vivo counterparts, indicating that these extracts
closely reflect the in vivo effects of virus infection.
Vesicular stomatitis virus (VSV) has been
shown to inhibit protein synthesis in suitable
host cells (4, 10, 13, 16, 18, 24, 29). The kinetics
and extent of inhibition are somewhat dependent
on the cell line and virus strain (14, 24). As can
be seen by analysis of the products by polyacryl-
amide gel electrophoresis, the cellular proteins
are inhibited, whereas the viral proteins flourish.
Stanners et al. (24) and Jaye et al. (10) have
shown that protein synthesis inhibition occurs at
the level of polypeptide chain initiation. Further-
more, Centrella and Lucas-Lenard (4) have ob-
served that virus infection causes a decrease in
initiation factor 2 activity in extracts from infect-
ed cells.
Lodish and Porter (13, 14) have suggested that
the inhibition of cellular protein synthesis results
from competition between viral and cellular
mRNAs for existing ribosomes. This rationale
follows if one considers that with viral infection,
there is a two- to threefold increase in total
translatable mRNA within 4 h of infection (10,
13, 14). This large increase in total mRNA
results from the extremely efficient transcription
of the viral genome.
Other data, however, suggest that specific
viral products other than viral mRNAs are in-
volved in the inhibition (16-18, 24). Stanners et
al. (24) have called the virus-specific product
involved in the inhibition the P function, and
they have isolated and partially characterized a
P- mutant (Rl) that has a lower capacity to
inhibit total protein synthesis than does its par-
ent wild type. Using UV light-inactivated virus,
Marvaldi et al. (17) have found that the inhibi-
tion of protein synthesis correlates with the
expression of the N protein gene. Such UV-
irradiated virus is incapable of secondary tran-
scription, and thus the total number of tran-
scripts in cells infected with this virus is greatly
reduced (6).
In an effort to understand the inhibition phe-
nomenon, we chose the UV light inactivation
technique to construct viruses that express the
inhibitory factor(s), yet do not produce signifi-
cant amounts of viral mRNA. This technique
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can be used because viral mRNA transcription is
sequential (1, 2) and therefore allows a succes-
sive inhibition of viral mRNA transcription (the
most UV-resistant transcript being that nearest
the transcription initiation site and the least UV-
resistant being that furthest from that site). Our
results show that the UV-inactivation curve was
biphasic with the HR strain of the Indiana sero-
type of VSV and monophasic with the Rl mu-
tant characterized by Stanners et al. (24). These
results suggest that protein synthesis inhibition
by the HR strain involves at least two viral
transcription products and that the Rl mutant
probably lacks one of these.
Finally, we prepared cell-free extracts from
the UV-irradiated, virus-infected cells and found
that the protein synthesis capacity of these ex-
tracts reflected quite closely that of their in vivo
counterparts. Therefore, these extracts will en-
able us to dissect the molecular mechanism of
protein synthesis inhibition by VSV.
MATERIALS AND METHODS
Cells and virus. Monolayers of mouse L-cells were
grown and maintained in Richter minimal essential
medium (Irvine Scientific Co.) plus 5% bovine calf
serum on plastic petri dishes at 37°C.
A heat-resistant strain of the Indiana serotype (HR-
C) of VSV was used throughout this study (8). The
preparation, storage, and analysis of this virus have
been described previously (10). The titer of this virus
stock was typically found to be 1.10 x 101" 0.25 x
1011 PFU/ml. The Rl mutant used in this study was
isolated by Stanners et al. (24). It is a revertant of the
double mutant T1026 and was generously supplied to
P. I. Marcus at the University of Connecticut by C. P.
Stanners. The Rl mutant was grown on Vero-Cl cells,
and the supermatant from these cells was collected at
18 h after infection. The clarified supernatant (10,000
x g for 10 min) was used as stock virus. Its titer was
typically 109 PFU/ml.
Infection of L-cells was essentially the same as
described previously by Wu and Lucas-Lenard (30).
Adsorption was for 45 min at 37°C.
UV irradiation of virus. The virus stock was diluted
(ca. 1/1,000) with phosphate-buffered saline to a con-
centration that would allow delivery of the desired
multiplicity of infection (MOI). The diluted virus was
transferred to a prewetted Falcon dish and kept on ice.
The virus was then irradiated with UV (average wave-
length [X], 254 nm) light from a General Electric
germicidal bulb. The lamp was calibrated against a
Blak-Ray ultraviolet meter (J-22S shortwave UV me-
ter; Ultraviolet Products, Inc.). At 90.5 cm from the
sample, the output of the lamp was 7.3 ± 1.0 ergs/mm2
per s; at 39.5 cm, the output was 26.0 ± 1.0 ergs/mm2
per s. The sample was then transferred to a sterile
plastic tube and kept on ice until used for infection.
Isotope labeling. Double-isotope labeling was per-
formed essentially as described previously by Mar-
valdi et al. (17). L-cells were prelabeled with 33.3 ,uCi
of 3H-amino acids mixture (NET-250; New England
Nuclear Corp.) per ml in Richter minimal essential
medium plus 5% bovine calf serum for 2 to 4 h and
pulse-labeled with 3 to 5 ,uCi of L-[35S]methionine
(specific activity, >1,000 Ci/mmol; NEG-009T; New
England Nuclear Corp.) in Richter minimal essential
medium plus 5% bovine calf serum for 30 min at the
times indicated in the figure legends and table foot-
notes. The infection was quenched by placing the cells
on ice. The cells were lysed either with 0.4% Triton X-
100 in RSB (as defined in Jaye et al. [10]) or with 0.1 N
NaOH. The Triton-treated lysates were transferred to
1.5-ml micro test tubes and centrifuged at 13,000 x g
for 5 min. The soluble fractions from the Triton- or
NaOH-treated lysates were neutralized, and then tri-
chloroacetic acid was added to a final concentration of
5%. The Triton-extracted material was heated at 90°C
for 5 min to deacylate the charged tRNA. The tri-
chloroacetic acid precipitates from the Triton- or
NaOH-treated lysates were filtered onto Whatman
GF/C filters and washed with 5 volumes of 5% tri-
chloroacetic acid followed by 5 volumes of 95% etha-
nol. The dried filters were analyzed in toluene/2a70
(Research Products International Corp.) scintillation
cocktail in a Tracor Mark III scintillation counter
programmed for double-label counting. Repeated ex-
periments have consistently allowed for determina-
tions of ±10o or better.
CeH-free systems. The protocol for the preparation of
the extracts was essentially that described by Jaye et
al. (10). Briefly, L-cells on 100-mm petri dishes were
given fresh medium and serum for 2 h before infection.
The cells were infected with unirradiated or irradiated
virus (MOI, 18 PFU per cell). The infection was
stopped by placing the plates on ice. The cells were
then gently scraped from the plates with a rubber
policeman. The cells were washed twice with ice-cold
Richter minimal essential medium and centrifuged.
The pelleted cells were suspended in 1.5 volumes of
hypotonic buffer (10) for 8 min on ice and then lysed in
a Dounce homogenizer. The lysate was centrifuged at
22,000 x g at 4°C for 15 min. The supernatant fraction
(S-22) was removed and adjusted with 10 times con-
centrated HKMD, as described previously by Jaye
et al. (10). The conditions for cell-free incuba-
tions were as described previously (10). The optimal
Mg2+ concentration for amino acid incorporation was
3.0 mM with extracts from both mock-infected cells
and cells infected with unirradiated (UV = 0
ergs/mm2) virus. The extracts from cells infected with
virus that had been irradiated at doses of 330 or 2,200
ergs/mm2 had broader Mg2+ optima (3 to 6 mM). The
Mg2+ concentration used in each incubation was 3.0
mM, and the ATP concentration was 0.9 mM. The
amount of protein in each lysate was determined as
described previously by Bradford (3). In each incuba-
tion, 2 to 5 pCi of L-[35S]methionine (>1,000 Ci/mmol)
was present.
The counts per minute of [35S]methionine incorpo-
rated into hot trichloroacetic acid-precipitable material
during 15 min of incubation at 32°C in a 50-pl reaction
mixture was used as a measure of protein synthesis.
The amount of methionine incorporated in terms of
picomoles was calculated by converting counts per
minute to disintegrations per minute and dividing the
disintegrations per minute by the specific radioactivity
of the methionine. The specific radioactivity of the
methionine was determined by measuring the L-methi-
onine pool size for each lysate, using the isotope
dilution technique. The values for the respective ly-
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sates were: mock infected, 34 ,uM; VSV (UV = 0 ergs/
mm2), 33 ,uM; VSV (UV = 330 ergs/mm2), 44 ,uM; and
VSV (UV = 2,200 ergs/mm2), 33 ,uM. Thus, picomoles
of methionine incorporated = disintegrations per min-
ute/(curies of radioactive methionine added/total me-
thionine pool size).
Polyacrylamide gel electrophoresis. The samples and
gels were prepared essentially as described previously
(4), except that the gels were poured as linear gradi-
ents from 7.5 to 15% acrylamide. X-Omat AR film
(Eastman Kodak Co.) was used for autoradiography.
Target size analysis. Target size analysis has been
described elsewhere (12). Briefly, the general expres-
sion for one-hit multitarget kinetics is NINO = me-rF,
where No is the number of targets present before
irradiation, N is the number of surviving targets, F is
the radiation dose (ergs per square millimeter), r is the
cross section for inactivation, or rather, the target size
(square millimeters per ergs), and m is the number of
targets which must be hit to cause an inactivation
event. Thus, the "surviving fraction" is NINO. In the
actual experiment for protein synthesis inhibition, the
surviving fraction was computed as N = (rate of
synthesis in mock-infected cells - rate in cells infected
with irradiated virus)/rate in mock-infected cells and
No = (rate of synthesis in mock-infected cells - rate in
cells infected with irradiated virus)/rate in mock-in-
fected cells.
Infectivity analysis was used as a calibration of the
rate of inactivation, since one hit to any part of the
genome is necessary and sufficient to inactivate repli-
cation. The size of the VSV (HR-C) genome was
assumed to be 3.6 x 106 daltons (27). The slope of the
curve for survival of protein synthesis inhibition as a
function of UV dose, relative to the slope of the curve
for survival of infectivity, was used to calculate the
fractional amount of the genome required to inhibit
protein synthesis.
RESULTS
The effect of UV-irradiation on the ability of
VSV to inhibit protein synthesis. Using UV irra-
diation to inactivate the viral genome, Marvaldi
et al. (17) showed that there is a correlation
between protein synthesis inhibition and expres-
sion of the N protein gene. To obtain a better
estimate of the target size necessary for protein
synthesis inhibition, we UV irradiated the virus
at different doses and then measured the ability
of those irradiated virus preparations to inhibit
protein synthesis. The protein synthesis rate
was determined by pulse-labeling cells for 30
min with [35S]methionine and measuring
[35S]methionine incorporation into hot trichloro-
acetic acid-insoluble material. In L-cells infect-
ed with VSV that had been irradiated with doses
of up to 550 ergs/mm2, there was an apparent
increase in the inhibition of protein synthesis
(Fig. 1A, upper curve). Analysis of the radiola-
beled products from this experiment by poly-
acrylamide gel electrophoresis (Fig. 1B) re-
vealed that the increase was, in fact, a result of a
decrease in viral protein synthesis. The gel anal-
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FIG. 1. Effect of UV-inactivated VSV on b-cell
protein synthesis. b-cells were prelabeled with
L-3H-anino acids for 2 h in fresh medium and serum.
The cells were infected at an MOI of 50 PFU per cell
with VSV that had been irradiated to the indicated
degree or were mock infected with phosphate-buffered
saline. The infected monolayer (0) or suspension
culture (A) of L-cells was incubated for 3.0 or 5.0 h,
respectively, at 370C, then pulse-labeled for 0.5 h at
370C with L-[35S]methionine in complete medium, ex-
cept for methionine, which was present at 10iM, plus
5% dialyzed bovine calf serum. The infection was
quenched, and a lysate was prepared with Triton, as
described in the text. (A) Inhibition of protein synthe-
sis by UV-irradiated virus. (B) Autoradiogram from a
sodium dodecyl sulfate-gel electrophoresis analysis in
which 100 jg of protein per lane was loaded: (A)
unirradiated, (B) 100 ergS/MM2, (C) 220 ergs/mm', (D)
330 ergs/mm', (E) 440 ergs/mm', (F) 550 ergs/mm', (G)
660 ergs/mm', (H) 1,100 ergS/MM2, (I) 2,200 ergS/MM2,
(J) mock infected, (K) unirradiated. L, L protein; G, G
protein; N/NS, N and NS proteins; M, M protein.
Arrows, b-cell proteins reappearing at high UV doses
(see text).
ysis also showed that at a dose between 440 and
550 ergs/mM2 (lanes E and F), the point of
maximal protein synthesis inhibition, the N pro-
tein was the only viral protein detected. It is
most important to note that cellular protein
synthesis was severely inhibited after infection
even when viral protein synthesis (and presum-
ably viral mRNA synthesis) was drastically re-
duced.
J. VIROL.
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FIG. 2. Analysis of extracts prepared from L-cells 
infected with UV-irradiated VSV. The preparation, 
incubation conditions, and analysis of the cell-free 
systems are described in the text. Symbols: 0,  mock 
infected; 0, VSV (UV = 0 ergs/mmZ); W, VSV (UV = 
330 ergslmm2); 0, VSV (UV = 2,200 ergs/mm2). Met, 
Methionine. 
Infecton of L-cells with VSV irradiated at 
doses greater than 550 ergs/mm2 resulted in a 
decreasing degree of protein synthesis inhibition 
(Fig. lA),  and, as shown by the arrows in Fig. 
lB ,  several host proteins began to reappear. 
Interestingly, even up to a dose of 3,500 
ergs/mm2 (Fig. lA),  there was a detectable 
amount of protein synthesis inhibition. This re- 
sidual amount varied from experiment to experi- 
ment and ranged from a minimum of 15% to a 
maximum of 50%. 
On some occasions (2 of 10 experiments) after 
infection of cells in monolayers or suspension 
culture, the UV inactivation curve looked some- 
what different; the initial point (0 ergs/mm2) 
represented the maximal amount of inhibition, 
and after UV irradiation, the inhibition was less 
and less (see lower curve in Fig. 1A). We have 
no satisfactory explanation for this observation 
at the moment, and studies designed to clarify 
this phenomenon are under way in our labora- 
tory. 
Comparison of [35~]rnethionine incorporation 
into protein in whole cells and in cell-free extracts. 
In these studies, we examined the extent to 
which extracts from infected cells reflected the 
effects of virus infection in vivo. We based these 
studies on the observation that when VSV is 
irradiated with different doses of UV light, pro- 
tein synthesis is inhibited to various extents. We 
rationalized that extracts prepared from cells 
infected with irradiated virus should reflect the 
in vivo protein synthesis activity of the cells. 
L-cells in monolayer cultures were mock in- 
fected or infected with unirradiated or irradiated 
vims, and 3.75 h after infection some of the 
cultures were harvested and lysed as described 
above. The remaining cultures were pulse-la- 
beled with [35S]methionine in vivo at the same 
time, so that in vitro and in vivo rates of protein 
synthesis could be compared. 
The amino acid pool size was estimated for 
each extract (mock infected, UV = 0, 330, or 
2,200 ergs/mm2) by isotope dilution techniques, 
and the incorporation data were corrected for 
differences in pool sizes, as discussed above. 
Incorporation of L-[35S]methionine was maximal 
in the extract from mock-infected cells and 
minimal in the extract from cells infected with 
vims irradiated at a dose of 330 ergs/mm2 (Fig. 
2). The extract from cells infected with unirradi- 
ated virus was less active than the mock-infect- 
ed extract, but more active than the extracts 
from cells infected with virus irradiated at a dose 
of 330 or 2,200 ergs/mm2. Hence, the cell-free 
lysates reflected to the whole cell experiments 
demonstrated in Fig. 1A in the ability of the 
lysates to incorporate L-[35S]methionine. 
The products of the in vitro radiolabel incor- 
poration experiments were examined by poly- 
acrylamide gel electrophoresis and were com- 
pared with the products labeled in vivo. There 
was a good qualitative correlation between the 
in vitro- and the in vivo-labeled products (Fig. 
3). (These gels cannot be viewed as quantitative 
indicators of protein synthesis, since the sam- 
ples labeled in vitro contained slightly different 
amounts of protein.) Fig. 3 also shows the 
presence of two apparently vims-specific bands 
migrating below the M protein in the gels of both 
in vivo- and in vitro-labeled proteins. The origin 
of the bands is unknown, and they disappeared 
after UV irradiation of the virus. Also, they 
were not always detected (Fig. 1B). Currently, 
we are trying to characterize these bands. When 
initiator [3SS]methionyl tRNA in the presence of 
100 p,M L-methionine was used in place of L- 
[35S]methionine to label proteins in extracts, 
similar results were obtained with respect to 
relative incorporation and labeled products 
made (data not shown). Thus, both elongation 
and initiation were taking place in these ex- 
tracts. 
Quantitatively, when the percentage of pro- 
tein synthesis (protein synthesis in infected 
cells/protein synthesis in mock-infected cells) 
was compared, there was a fair correlation be- 
tween the in vivo and in vitro labeling experi- 
ments, as shown in Table 1. The lysates from 
cells infected with vims which had been irradiat- 
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TABLE 1. Comparison of in vivo with in vitro 
protein synthesis activities of UV-irradiated virus- 
infected cellsa 
W dose 
(er&mm2) 
% of mock-infected 
cell activity 
In vivo In vitro 
- - -  
0 66 63 
330 53 42 
2,200 65 53 
" L-cells were infected as described in the text. For 
the in vivo values, two plates for each condition were 
pulse-labeled from 3.5 to 4.0 h after infection with 
[35S]methionine in complete medium, except for me- 
thionine, which was present at 10 pM, and 5% dia- 
lyzed calf serum. These cells were extracted with 
Tritqn and prepared as described in the text. Protein 
quantity was determined for each extract, and the 
incorporation was computed as counts per minute per 
microgram of protein. Values from the in vitro assay 
were extracted from the linear region of the curves 
from Fig. 2. Values shown were computed from: 
picomoles of methionine incorporated per 200 pg of 
protein. 
FIG. 3. Comparison of the gel electrophoretic pat- 
terns of proteins from mock-infected or VSV-infected 
L-cells labeled in vivo or in vitro. This is an autoradio- 
gram of an electrophoretic analysis on a 7.5 to 15% 
polyacrylamide gel. Lanes 1 through 4, Cells pulse- 
labeled in vivo at 3.5 to 4.0 h after infection and lysed 
with Triton; 100 pg protein was added in each lane. 
Lanes 5 through 8, Cell-free incubations described in 
the text and depicted in Fig. 2: lane 5, 126 pg of 
protein; lane 6, 175 pg of protein; lane 7, 159 pg of 
protein; and lane 8,170 pg of protein. Lanes 1 and 5, 
mock infected; lanes 2 and 6, unirradiated virus; lanes 
3 and 7, virus irradiated at 330 ergs/mm2; and lanes 4 
and 8, virus irradiated at 2,200 ergs/mm2. The autora- 
diogram of the proteins labeled in vitro (lanes 5 
through 8) was exposed for 10 days, whereas that of 
the proteins labeled in vivo (lanes 1 through 4) was 
exposed for 4 days. L, L protein; G, G protein; NMS, 
N and NS proteins; M, M protein. 
ed at a dose of 330 or 2,200 ergs/mm2 were 
slightly less active than their in vivo counter- 
parts. 
Analysis of small viral transcription product 
necessary for protein synthesis inhibition. Cellu- 
lar protein synthesis was still inhibited from 15 
to 40% at UV doses in which transcription 
would have been reduced to of that with 
unirradiated virus (Fig. 1A and B; Table 1 and 
Fig. 4). This latter value was determined by a 
plaque reduction assay at a UV dose of 440 
ergs/mm2, and the calculation was based on the 
assumption that one hit anywhere in the viral 
genome would inhibit replication and therefore 
secondary transcription. These results suggest- 
ed that protein synthesis inhibition involved still 
another viral component that was less sensitive 
or insensitive to UV irradiation. 
The characteristics of this second component 
were examined first by determining the time 
necessary for expression of protein synthesis 
inhibition. If virion proteins would suffice, then 
one might expect to see inhibition soon after 
virus adsorption. In cells that were infected by 
virus that had received a UV light dose of 4,400 
ergslmm2, there was little inhibition until 2.25 h 
after infection, at which time a 33% inhibition 
was observed (Table 2). At 24 h after infection 
the inhibition was 40%, suggesting that the effect 
was stable. Since the inhibition was time depen- 
dent, it seemed probable that transcription of the 
viral genome was necessary. This suggestion 
was supported by the observation that when the 
virus was heated to 50°C under conditions in 
which virion-associated transcriptase activity 
was lost (13,  the virus was no longer capable of 
inhibiting cellular protein synthesis (data not 
shown). Also, when the virus was subjected to 
very lar e doses of UV irradiation (>18,000 4 ergslmm ), it lost its capacity to inhibit cellular 
protein synthesis (data not shown). The product 
inactivated at this high UV dose will henceforth 
be referred to as the small transcription product. 
The other viral product that was inactivated by 
UV doses of up to 1,000 ergs/mm2 will be called 
the large transcription product. 
Analysis of a P- mutant. We wished to deter- 
mine if the R1 mutant of Stanners et al. (24) 
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TABLE 2. Rate and multiplicity dependence of 
appearance of small transcription product 
% of mock-infected cell activityb at the follow- 
Time after ing dose for MOI (PFUIcell)' of: 
adsop 4,400 ergs/mm2 UV 0 ergs/mm2 UV tion, (h)" 
2.1 21 2.1 21 
0.25 90 98 NDd ND 
1.25 93 93 ND ND 
2.25 77 77 61 59 
24 ND 60 
" L-cell monolayers were infected or mock infected 
as described in the text. The cells were pulse-labeled 
for 30 min at the indicated times with 3H-amino acids 
in complete medium plus 5% dialyzed calf serum. 
The cells were extracted with Triton, as described 
in the text, the protein quantity was determined for 
each sample, and the incorporation was computed as 
counts per minute per microgram of protein. 
' Stock virus was diluted to yield an MOI of 21. 
Then after irradiation, a portion was diluted 1/10 for an 
MOI of 2.1. 
ND, Not done. 
showed the same UV inactivation curve for 
protein synthesis inhibition as the wild type. 
Subconfluent monolayers of L-cells were infect- 
ed with UV-irradiated R1 mutant at three differ- 
FIG. 4. Effect of UV-irradiated wild-type and R1 
virus on L-cell protein synthesis. L-cells were treated 
as described in the legend to Fig. 1. Virus was irradiat- 
ed to the indicated degree. The infected or mock- 
infected cells were incubated for 3.5 ha t  37'C and then 
pulse-labeled with L-[35S]methionine in complete me- 
dium plus bovine calf serum for 0.5 h at 37OC. The 
infection was quenched, and the medium was extract- 
ed with 0.1 N NaOH, as described in the text. The 
upper three curves represent infections with the R1 
virus at three MOIs: (A) 2.4; (0) 43; (.) 300. The 
lower curve represents an infection with the wild-type 
virus at an MOI of 13. 
ent MOIs. The data (Fig. 4) showed the presence 
of a UV-sensitive region analogous to that of the 
wild-type virus. However, inactivation of the 
region of the genome specifying the large tran- 
scription product resulted in a virus that was 
unable to inhibit protein synthesis, suggesting 
that the small transcription product was not 
inhibitory in this mutant. The inhibition was 
found to be multiplicity dependent. The lower 
curve on this graph shows the effect of infection 
by wild-type VSV on L-cell protein synthesis. 
To learn more about the properties of protein 
synthesis inhibition by the R1 mutant, we com- 
pared the multiplicity dependence of this mutant 
with that of the wild-type virus. The data (Fig. 5) 
showed a large difference between the wild type 
and the mutant in the MOI needed to inhibit 
protein synthesis. Three experiments with the 
wild-type virus are presented to demonstrate 
that regardless of the extent of protein synthesis 
inhibition, 63% of the maximal inhibition was 
present at an MOI of 1 PFU per cell. This is 
compatible with a one-hit kinetic model with 
respect to PFU per cell. The maximal inhibition 
of protein synthesis for R1 was not reached until 
the MOI was 500 PFU per cell (data not shown). 
These results fit a kinetic model in which ap- 
proximately 60 PFU per cell are necessary to 
obtain 63% of the maximum inhibition. At the 
1 I 
10 20 JD 40 
Multiplicity of lnfect~on 
FIG. 5. Effect of MOI on protein synthesis inhibi- 
tion in L-cells infected by wild-type VSV or by the R1 
mutant. L-cells were treated as described in the text. 
Virus was diluted and used to infect L-cells for both 
protein synthesis and infectivity measurements. The 
abscissa was corrected to the measured titer for each 
experiment. The lower three curves represent three 
experiments with wild-type virus done on different 
dates. The upper curve represents an experiment with 
the R1 virus. 
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multiplicities of R1 tested, there was no measur- 
able inhibition that could be attributed to the 
small transcription product (see Fig. 4). 
Target sizes. The target sizes of the UV- 
sensitive regions of the wild-type and of the R1 
mutant genomes were determined as described 
above. The upper two curves in Fig. 6 represent 
the inactivation of the large transcription prod- 
uct inhibitor of protein synthesis. The size of 
the wild-type virus inhibitor was calculated to  be 
373 ? 71 nucleotides and that of the R1 mutant 
inhibitor was calculated to be 807 2 125 nucleo- 
tides. The solid line in Fig. 6 represents the loss 
of infectivity as  a function of UV dose. 
Figure 7 shows the data for the inactivation of 
the small transcription product of the wild-type 
virus. The statistical analysis was as described 
for Fig. 6.  The target size was 42 2 12 nucleo- 
tides. 
DISCUSSION 
This report shows our attempts to define more 
precisely the region(s) of the VSV genome nec- 
essary for protein synthesis inhibition, using the 
UV Dose (ergs/mm2 ) 
FIG. 6.  Target size analysis of the large transcrip- 
tion product of the VSV genome involved in protein 
synthesis inhibition. Target size analysis is described 
in the text. The loss of infectivity as a function of UV 
dose is indicated by the steep solid line. The slope of 
this curve was -9.81 x lo-' mm'lerg for the wild-type 
virus and -8.42 x lo-'  mm'lerg for the Rl mutant. 
The loss of protein synthesis inhibition as a function of 
UV dose is indicated by the data for the wild-type 
virus (0) and the R1 mutant (0). The slope of the 
curve was -3.56 x f 0.70 x mm21erg for 
the wild-type virus and -7.70 x t 1.25 x 
mm2/erg for the R1 mutant. These data represent a 
composite of six and two independent experiments. 
respectively. The data points are the means of the data 
collected, and the error bars are the standard devi- 
ations of the data collected. The curve drawn through 
the points is a least-squares best-fit analysis of all of 
the data collected. 
0 1 I I 
0 4 8 12 16 
U V Dose (wgs/mm x 
FIG. 7. Target size analysis ol' the small transcrip- 
tion product of the VSV genome involved in protein 
synthesis inhibition. The target size analysis is de- 
scribed in the text. The loss of protein synthesis 
inhibition as a function of UV dose is depicted by two 
independent experiments: (0) an experiment in which 
only one data point was taken at each irradiation dose; 
(0) a second experiment in which four data points 
were taken at each irradiation dose and averaged. The 
slope of this curve is -4.5 x 1 0 -  t 1.08 x lo-'  mm2/ 
erg. The statistical analysis was as described in the 
legend to Fig. 6 . .  
technique of UV mapping. Wertz and Youngner 
(29) suggested that two mechanisms are in- 
volved in the inhibition of cell protein synthesis 
by VSV: an initial, UV-insensitive inhibition and 
a progressive, UV-sensitive inhibition. N o  UV- 
insensitive inhibition of protein synthesis was 
detected in our studies. In fact, the UV inactiva- 
tion curve for protein synthesis inhibition shown 
in this paper was biphasic, suggesting that two 
transcription products are involved in the inhibi- 
tion. The target sizes of the two UV-sensitive 
regions of the VSV genome were calculated to 
be approximately 375 and 42 nucleotides. The 
large transcription product inhibitor accounted 
for 35 to 40% of the total inhibition, and the 
small transcription product inhibitor accounted 
for 60 to 65% of the total inhibition. Neither of 
these putative inhibitors corresponded in size to 
any of the known viral mRNA species. 
The origin of these transcripts is uncertain. 
Recent reports have noted the presence of sev- 
eral small RNA species during in vitro transcrip- 
tion (9, 20, 21, 23, 26). These small RNAs arise 
from the 3'-proximal region of several of the 
viral genes and represent the initiation of tran- 
scription at defined sites. Their initiation is 
independent of that of the leader RNA (5). Some 
of the small RNA transcripts are capped (9, 23, 
26) and are highly resistant to UV irradiation (9, 
26; J. D. Keene. personal communication). The 
capped, UV-resistant R N A  species are tran- 
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scribed from the 3'-proximal region of the N 
protein gene and contain a potential ribosome 
binding site (7,22). Because of their similarity in 
size and UV resistance, these small RNA spe- 
cies may correspond to the putative small tran- 
scription product inhibitor reported in this pa- 
per. If so, the effect of the inhibitor on protein 
synthesis could be to tie up ribosomes, since 
initiation of protein synthesis could conceivably 
occur on the fragment. Since there are no chain 
termination signals on the fragment, ribosomes 
would remain stalled, and the 40s and 60s 
subunit pools would be depleted. 
The putative large transcription product (375 
nucleotides) could also be derived from the N 
protein gene in view of the recent isolation and 
characterization by Banerjee and co-workers 
(25; personal communication) of a 9 s  viral RNA 
species corresponding to the 5'-terminal tran- 
scription product of the N protein gene. This 9 s  
RNA species is present in vivo and in vitro, 
contains approximately 400 nucleotides, is 
capped, has three potential ribosome binding 
sites, and is transcribed in equal molar quantities 
relative to the N protein mRNA. 
VSV infection results in the inhibition of cellu- 
lar RNA synthesis in addition to cellular protein 
synthesis (28, 30). The current evidence sug- 
gests that the leader RNA, which contains 48 
nucleotides ( 9 ,  is involved in this process (11, 
19). If efficient protein synthesis is dependent on 
continuous RNA synthesis, then any perturba- 
tion in the rate of RNA synthesis would affect 
the rate of protein synthesis. Thus, should the 
putative small transcription product be identi- 
fied as leader RNA, its effect on protein synthe- 
sis could be a consequence of RNA synthesis 
inhibition. 
These possible mechanisms are only specula- 
tive, and there is no evidence to favor one over 
another. It is probable that more than one mech- 
anism is operating, in view of our results with 
the R1 mutant. We are in the process of identify- 
ing the putative transcription products described 
in this report. 
The R1 mutant described by Stanners et al. 
(24) poses an interesting problem. As shown in 
Fig. 4, 5, and 6, the R1 mutant behaved quite 
differently from the wild-type virus in a number 
of respects. First, a much higher MOI was 
needed to elicit inhibition of protein synthesis 
(see Fig. 5). One infectious particle per cell was 
sufficient for 63% inhibition by the wild-type 
virus, whereas as many as 60 infectious particles 
per cell were needed by the mutant. Secondly, 
the UV inactivation curve was monophasic in 
the case of the mutant (Fig. 4), as opposed to 
being biphasic in the case of the wild-type virus. 
It is possible that the P function is related to the 
role of the small transcription product. Our 
preliminary experiments show that in cells in- 
fected with the R1 mutant, RNA synthesis inhi- 
bition occurred to a much lesser extent than in 
cells infected with the wild-type virus. These 
findings suggest that there is some link between 
RNA and protein synthesis inhibition. 
These studies have also reinforced our con- 
tention (10) that the inhibition of protein synthe- 
sis by VSV does not result from competition 
between viral and cellular mRNA species for 
available ribosomes in the cell (13, 14). Until a 
very high dose of UV irradiation was applied to 
VSV, the virus was still capable of inhibiting 
protein synthesis. Under these conditions little, 
if any, viral mRNA synthesis occurred, as ascer- 
tained by the low amount of viral proteins syn- 
thesized (see Fig. 1B and Fig. 3). 
The comparative study (Fig. 3 and Table 1) of 
the translation of the protein products synthe- 
sized by unirradiated and UV-irradiated VSV in 
vivo and in vitro showed that the same species 
of proteins were made. This finding will allow us 
to study this inhibition in vitro. 
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